Note: Advaxis's revenues are gauged from an analysis of company filings.
Advaxis has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
December 13, 2012
Complete list of funding rounds and total amounts in the Company Report
Trademark applications show the products and services that Advaxis is developing and marketing.
Advaxis doesn't have any recent trademark applications, indicating Advaxis is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
ADVAXIS Pharmaceuticals, pharmaceutical compositions, and pharmaceutical preparations, all for the treatment of cancer and for immunotherapy
ADXS11-001 Pharmaceutical preparations for the treatment of cancer
MINE BIOPHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF IMMUNOLOGICAL CONDITIONS; BIOPHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF TUMORS; BIOPHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF IMMUNE SYSTEM CONDITIONS; MEDICINAL PREPARATIONS FOR THE TREATMENT OF INFECTIOUS DISEASES AND FOR USE IN ONCOLOGY; BIOPHARMACEUTICAL PREPARATIONS FOR PERSONALIZED CANCER IMMUNOTHERAPIES AND IMMUNO-ONCOLOGY THERAPIES
Determine whether Advaxis grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof Advaxis is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
A competitive analysis shows these companies are in the same general field as Advaxis, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are in the same general field as Advaxis and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.